D. Reilly, M. Taylor, N. Beattie, et al.,
Is Evidence for Homoeopathy Reproducible?
Lancet, December 10, 1994, 344:1601-6.
This study successfully reproduced evidence from two previous double-blinded trials all of which used the same model of homeopathic immunotherapy in inhalant allergy. In this third study, 9 of 11 patients on homeopathic treatment improved compared to only 5 of 13 patients on placebo. The researchers concluded that either homeopathic medicines work or controlled studies don’t. Their work has again be recently replicated and is
submitted for publication. (See Is Homeopathy a Placebo Response? Lancet 1986, below.)
D. Reilly, M. Taylor, C. McSherry,
Is Homeopathy a Placebo Response? Controlled Trial of Homeopathic Potency with Pollen in Hayfever as Model, Lancet, October 18, 1986, 881-86.
The double-blind study compared a high dilution homeopathic preparation of grass pollens against a placebo in 144 patients with active hay fever. The study method considered pollen counts, aggravation in symptoms and use of antihistamines and
concluded that patients using homeopathy showed greater improvement in symptoms than those on placebo, and that this difference was reflected in a significantly reduced need for antihistamines among the homeopathically treated group. The results confirmed those of the pilot study and demonstrate that
homeopathic potencies show effects distinct from those of the placebo.
(The editorial for this issue of Lancet 1994;344(8937):1585) is interesting. It is presented here in its entirety:
(I’m sorry, but we cannot have copyrighted articles reproduced on our board. Please either paraphrase them or provide a link to the article. Thanks - Jill)
Vittorio Elia and Marcella Niccoli
Thermodynamics of extremely diluted aqueous solutions. Annals of the New York Academy of Sciences, June 1999
An extensive thermodynamic study has been carried out on aqueous solutions obtained through successive dilutions and succussions of 1% in weight of some solutes up to extremely diluted solutions, (less than 1x10-5 mol kg-1) obtained via several
1/100 successive dilution processes.
P.C. Endler, W. Pongratz, G. Kastberg, et al.,
The Effect of Highly Diluted Agitated Thyroxine on the Climbing Activity of Frogs
Veterinary and Human Toxicology, 1994, 36:56.
This, and the study below, show that a homeopathic medicine can influence the growth and development of tadpoles in water.
P.C. Endler, W. Pongratz, R. van Wijk, et al., Transmission of Hormone Information by Non-molecular Means,
FASEB Journal, 1994, 8, Abs.2313.
This, and the study above, show that a homeopathic medicine can influence the growth and development of tadpoles in water.
J. Kleijnen, P. Knipschild, G. ter Riet,
Clinical Trials of Homeopathy
British Medical Journal, February 9, 1991, 302:316-323.
This is the most widely cited meta-analysis of clinical research prior to 1991. This meta-analysis reviewed 107 studies of homeopathic medicines, 81 of which (or 77%) showed positive effect.
NOT ALL META ANALYSES SHOW ONLY POSITIVE ARTICLES
Of the best 22 studies, 15 showed efficacy. The researchers concluded: “The evidence presented in this review would probably be sufficient for establishing homeopathy as a
regular treatment for certain indications.” Further, “The amount of positive evidence even among the best studies came as a
surprise to us.”
Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study. Arch Otolaryngol Head Neck Surg 1998 Aug;124(8):879-85 (ISSN: 0886-4470)
Weiser M; Strosser W; Klein P
Biologische Heilmittel Heel GmbH, Baden-Baden, Germany. weiser.michael@heel.de.
OBJECTIVE: To compare the efficacy and safety of a homeopathic remedy (Vertigoheel, Heel Inc, Albuquerque, NM) vs betahistine
hydrochloride (active control) in the treatment of patients with vertigo of various origins in a confirmative equivalence trial. DESIGN:
Randomized (1:1) double-blind controlled clinical trial. SETTING: Fifteen study centers (general practice) in Germany between November 1995 and November 1996. SUBJECTS: A total of 119 patients with vertigo of various origins (from whom 105 patients could be analyzed asintended per protocol). MAIN OUTCOME MEASURES: Frequency, duration, and intensity of vertigo attacks. RESULTS: Both homeopathic and conventional treatments showed a clinically relevant reduction in the mean frequency, duration, and intensity of the vertigo attacks. The therapeutic equivalence of the homeopathic remedy and betahistine was established statistically. CONCLUSIONS: Concerning the main
efficacy variable, therapeutic equivalence between the homeopathic remedy and betahistine could be shown with statistical significance(confirmative analysis). Both remedies reduced the frequency, duration, and intensity of vertigo attacks during a 6-week treatment period. Also, vertigo-specific complaints were significantly reduced in both treatment groups.
Homeopathic treatment of mild traumatic brain injury: A randomized, double-blind, placebo-controlled clinical trial. J Head Trauma Rehabil 1999 Dec;14(6):521-42 (ISSN: 0885-9701)
Chapman EH; Weintraub RJ; Milburn MA; Pirozzi TO; Woo E Harvard University School of Medicine, Boston, MA, USA.
BACKGROUND: Mild traumatic brain injury (MTBI) affects 750,000 persons in the United States annually. Five to fifteen percent have persistent dysfunction and disability. No effective, standard pharmacological treatment exists specifically for this problem. We designed a pilot research project to study the clinical effectiveness of homeopathic medicine in the treatment of persistent MTBI. METHOD: A randomized, ouble-blind, placebo-controlled trial of 60 patients, with a four-month follow-up (N = 50), was conducted at Spaulding Rehabilitation Hospital (SRH). Patients
with persistent MTBI (mean 2.93 years since injury, SD 3.1) were randomly assigned to receive a homeopathic medicine or placebo. The primary outcome measure was the subject-rated SRH-MBTI Functional Assessment, composed of three subtests: a Difficulty with Situations Scale (DSS), a Symptom Rating Scale (SRS), and a Participation in Daily Activities Scale (PDAS). The SRH Cognitive-Linguistic Test Battery
was used as the secondary measure. RESULTS: Analysis of covariance demonstrated that the homeopathic treatment was the only
significant or near-significant predictor of improvement on DSS subtests (P =.009; 95% CI -.895 to -.15), SRS (P =.058; 95% CI -.548 to.01)and the Ten Most Common Symptoms of MTBI (P =.027; 95% CI -.766 to -.048). These results indicate a significant improvement from the homeopathic treatment versus the control and translate into clinically significant outcomes. CONCLUSIONS: This study suggests that homeopathy may have a role in treating persistent MTBI. Our findings require large-scale, independent replication.
While you chew on these for awhile, I’ll continue to look for the article on NMR and the other one on plant and animal effects.
Tom
[Note: This message has been edited by JillGat]